Anebulo Pharmaceuticals (ANEB) Non Operating Interest Expenses (2021 - 2025)
Anebulo Pharmaceuticals' Non Operating Interest Expenses came in at $17,439 for fiscal Q2 2026 (quarter ended Dec 31, 2025), down 82.6% from $100,000 a year earlier and unchanged from the prior quarter.
Anebulo Pharmaceuticals (ANEB) Non Operating Interest Expenses (2021 - 2025) Analysis & Trends
Over the trailing twelve months to Dec 31, 2025, Anebulo Pharmaceuticals reported Non Operating Interest Expenses of $315,485, down 14.3% year-over-year; for FY2025 (ended Jun 30, 2025), it came in at $400,000, up 100.0% from FY2024.
- Non Operating Interest Expenses carries a five-year compound annual growth rate of 215.2% (FY2020 to FY2025).
- Going back by fiscal year, Non Operating Interest Expenses was $200,000 in FY2024 and $11,767 in FY2021 (+815.0%).
- The five-year range for quarterly Non Operating Interest Expenses is $3,701 (fiscal Q3 2021) to $245,182 (fiscal Q3 2025).
- Year-over-year, Non Operating Interest Expenses has declined for three consecutive quarters, with growth averaging 58.5% over the last five quarters.
- Business Quant data shows ANEB's Non Operating Interest Expenses at $17,439 (Q1 2026), $35,425 (Q4 2025) and $245,182 (Q3 2025) in the three fiscal quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 281.00 Mn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -462.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -435.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 673.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 247.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Anebulo Pharmaceuticals | 13.15 Mn | 13.15 Mn | - | 17,439.00 |
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 17,439.00 |
| Sep 30, 2025 | 17,439.00 |
| Jun 30, 2025 | 35,425.00 |
| Mar 31, 2025 | 245,182.00 |
| Dec 31, 2024 | 100,000.00 |
| Sep 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 108,466.00 |
| Mar 31, 2024 | 59,696.00 |
| Dec 31, 2023 | 31,838.00 |
| Mar 31, 2021 | 3,701.00 |
Anebulo Pharmaceuticals Non Operating Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=ANEB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-interest-expenses", "ticker": "ANEB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=ANEB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();